| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.40B | 6.79B | 4.19B | 2.68B | 3.62B | 3.38B |
| Gross Profit | 5.53B | 5.11B | 2.99B | 1.70B | 2.36B | 2.19B |
| EBITDA | 808.01M | 752.09M | 676.04M | 268.88M | 404.70M | 403.95M |
| Net Income | 904.16M | 781.21M | 461.10M | 147.10M | 338.89M | 203.46M |
Balance Sheet | ||||||
| Total Assets | 3.95B | 3.60B | 3.13B | 3.15B | 2.27B | 2.22B |
| Cash, Cash Equivalents and Short-Term Investments | 799.88M | 732.71M | 914.50M | 1.17B | 157.26M | 174.24M |
| Total Debt | 300.83M | 111.67M | 165.57M | 728.20M | 285.04M | 544.10M |
| Total Liabilities | 1.45B | 1.36B | 1.10B | 1.44B | 1.32B | 1.64B |
| Stockholders Equity | 2.43B | 2.19B | 2.01B | 1.71B | 949.98M | 578.95M |
Cash Flow | ||||||
| Free Cash Flow | 473.06M | 304.38M | 657.69M | -23.51M | 269.46M | 124.56M |
| Operating Cash Flow | 715.30M | 546.95M | 746.16M | 36.56M | 335.19M | 265.97M |
| Investing Cash Flow | -74.30M | -187.03M | -457.49M | -66.78M | -55.29M | -6.95M |
| Financing Cash Flow | -556.10M | -595.67M | -737.21M | 1.03B | -289.56M | -239.93M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$2.95B | 13.87 | 6.65% | 5.93% | 9.72% | -10.15% | |
73 Outperform | HK$33.19B | 13.36 | 10.69% | 5.36% | -3.48% | -24.11% | |
66 Neutral | HK$38.13B | 15.02 | 29.64% | 1.84% | 36.70% | 22.26% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | HK$35.99B | 35.24 | 39.62% | 2.53% | 20.78% | 18.37% | |
43 Neutral | HK$16.47B | -28.79 | -6.08% | 5.02% | 2.79% | -170.67% | |
41 Neutral | HK$981.03M | -15.76 | -12.38% | ― | 39.29% | -71.82% |
Shanghai Chicmax Cosmetics Co., Ltd. announced amendments to its Articles of Association following the issuance and allotment of 35,223 H Shares under its RSU Scheme. This adjustment reflects changes in the company’s registered share capital and total number of shares, aligning with resolutions passed at an extraordinary general meeting in December 2023.
Shanghai Chicmax Cosmetics Co., Ltd. has announced the fourth round of granting Restricted Share Units (RSUs) to five employees, totaling 51,130 RSUs, which represents 0.01% of the company’s total shares. This move is intended to recognize and incentivize the employees’ past and expected future contributions to the company’s growth and success, with a vesting period of less than 12 months and performance targets set for eligibility.
Shanghai Chicmax Cosmetics Co., Ltd. has announced an interim cash dividend of RMB 0.5 per share for the six months ending June 30, 2025, with a corresponding payment in Hong Kong dollars. The announcement includes details on withholding tax rates applicable to different categories of shareholders, reflecting the company’s compliance with international tax treaties. This dividend declaration is part of the company’s ongoing commitment to returning value to its shareholders and may influence investor sentiment positively.
Shanghai Chicmax Cosmetics Co., Ltd. announced the results of its second extraordinary general meeting for 2025, where all proposed resolutions were approved. These included the payment of an interim dividend, amendments to the Articles of Association, and the appointment of new directors. The approval of these resolutions reflects strong shareholder support and is likely to impact the company’s governance structure and shareholder returns positively.
Shanghai Chicmax Cosmetics Co., Ltd. has announced the composition of its board of directors, highlighting the roles and functions of each member. The board includes executive directors, an employee representative director, and independent non-executive directors, with specific assignments to various board committees. This announcement provides clarity on the governance structure and could impact the company’s strategic direction and stakeholder confidence.
Shanghai Chicmax Cosmetics Co., Ltd. has announced that it will hold its second extraordinary general meeting in 2025 to discuss several key resolutions. These include the approval of an interim dividend, amendments to governance policies, and the appointment of an executive director. Additionally, the company is considering the abolition of its Supervisory Committee and changes to its Articles of Association and procedural rules, which could impact its corporate governance structure and operational efficiency.